These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5688670)

  • 1. [Demonstration of specific antigens in spontaneous and induced mouse neoplasms].
    Stück B
    Zentralbl Veterinarmed B; 1968 Feb; 15(1):73-80. PubMed ID: 5688670
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on histocompatibility antigens in an inbred mouse strain showing spontaneous mammary tumour and leukaemia.
    Nair PN; Gangal SG
    Indian J Cancer; 1976 Dec; 13(4):345-50. PubMed ID: 1022680
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological studies on virus and cell interaction with a mouse leukemia virus].
    Pasternak G; Graffi A
    Zentralbl Veterinarmed B; 1968 Feb; 15(1):65-72. PubMed ID: 4300993
    [No Abstract]   [Full Text] [Related]  

  • 4. Actively induced immune resistance to the experimental Tyzzer's disease of mice.
    Fujiwara K; Kurashina H; Maejima K; Tajima Y; Takagaki Y; Naiki M
    Jpn J Exp Med; 1965 Aug; 35(4):259-75. PubMed ID: 5295569
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization of mice against experimental Escherichia coli infection.
    Huygelen C; Fasseaux P; Dobrescu L
    Zentralbl Veterinarmed B; 1971 Dec; 18(10):761-9. PubMed ID: 4948112
    [No Abstract]   [Full Text] [Related]  

  • 6. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas.
    Coggin JH; Adkinson L; Anderson NG
    Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448
    [No Abstract]   [Full Text] [Related]  

  • 7. [Decline of the malignancy of a cell strain in mice follwoing chronic infection in vitro by the Rauscher leukemia virus].
    Barbieri D; Barski G
    Rev Fr Etud Clin Biol; 1968; 13(7):703-6. PubMed ID: 5726635
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proceedings: Immuno-chemical treatment of cancer in rats].
    Goto T; Sendo F; Hosokawa M; Kobayashi H
    Hokkaido Igaku Zasshi; 1974 Mar; 49(2):154-5. PubMed ID: 4476700
    [No Abstract]   [Full Text] [Related]  

  • 10. [Natural resistance and acquired immunity in experimental tuberculosis].
    Lévy FM; Conge G; Mauss H
    Bull Int Union Tuberc; 1968 Dec; 41():39-41. PubMed ID: 5710259
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expression of virus-specific RNA in cells of mice infected with Mazurenko and Rauscher viruses].
    Komissarova EV; Kiselev FL
    Biull Eksp Biol Med; 1980 Apr; 89(4):446-9. PubMed ID: 6248149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of AKR mice to lymphoid leukemia associated with a chronic protozoan infection, Besnoitia jellisoni.
    Lunde MN; Gelderman AH
    J Natl Cancer Inst; 1971 Aug; 47(2):485-8. PubMed ID: 5559245
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex.
    Fischinger PJ; Moore CO; O'Connor TE
    J Natl Cancer Inst; 1969 Apr; 42(4):605-22. PubMed ID: 5775808
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
    Novichenko NL; Struk VI
    Eksp Onkol; 1984; 6(3):29-32. PubMed ID: 6499739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 16. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
    Kobrin BJ; Naor D; Klein BY
    J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic properties of canine transmissible venereal sarcoma.
    Powers RD
    Am J Vet Res; 1968 Aug; 29(8):1637-45. PubMed ID: 5690687
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus.
    Hansen GM; Paturzo FX; Smith AL
    Lab Anim Sci; 1999 Aug; 49(4):380-4. PubMed ID: 10480642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.